As of 2026-04-09, the EV/EBITDA ratio of Thermo Fisher Scientific Inc (TMO) is 15.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMO's latest enterprise value is 216,558.33 mil USD. TMO's TTM EBITDA according to its financial statements is 13,882.00 mil USD. Dividing these 2 quantities gives us the above TMO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 19.5x | 16.8x |
| Forward P/E multiples | 19.5x - 20.7x | 20.0x |
| Fair Price | 463.10 - 648.46 | 537.60 |
| Upside | -8.0% - 28.8% | 6.8% |
| Date | EV/EBITDA |
| 2026-04-08 | 15.60 |
| 2026-04-07 | 15.23 |
| 2026-04-06 | 15.19 |
| 2026-04-02 | 15.28 |
| 2026-04-01 | 15.36 |
| 2026-03-31 | 15.28 |
| 2026-03-30 | 14.97 |
| 2026-03-27 | 14.79 |
| 2026-03-26 | 15.21 |
| 2026-03-25 | 15.26 |
| 2026-03-24 | 15.25 |
| 2026-03-23 | 14.92 |
| 2026-03-20 | 14.82 |
| 2026-03-19 | 14.71 |
| 2026-03-18 | 14.56 |
| 2026-03-17 | 14.78 |
| 2026-03-16 | 14.70 |
| 2026-03-13 | 14.55 |
| 2026-03-12 | 14.86 |
| 2026-03-11 | 15.39 |
| 2026-03-10 | 15.51 |
| 2026-03-09 | 15.77 |
| 2026-03-06 | 15.56 |
| 2026-03-05 | 16.01 |
| 2026-03-04 | 15.85 |
| 2026-03-03 | 15.72 |
| 2026-03-02 | 15.74 |
| 2026-02-27 | 16.07 |
| 2026-02-26 | 16.05 |
| 2026-02-25 | 15.87 |
| 2026-02-24 | 15.92 |
| 2026-02-23 | 15.95 |
| 2026-02-20 | 15.80 |
| 2026-02-19 | 15.91 |
| 2026-02-18 | 15.87 |
| 2026-02-17 | 15.55 |
| 2026-02-13 | 15.64 |
| 2026-02-12 | 15.77 |
| 2026-02-11 | 16.23 |
| 2026-02-10 | 16.57 |
| 2026-02-09 | 16.76 |
| 2026-02-06 | 16.65 |
| 2026-02-05 | 16.64 |
| 2026-02-04 | 17.25 |
| 2026-02-03 | 17.38 |
| 2026-02-02 | 17.70 |
| 2026-01-30 | 17.61 |
| 2026-01-29 | 17.97 |
| 2026-01-28 | 18.40 |
| 2026-01-27 | 18.82 |